Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization

被引:40
作者
Kivipensas, P
Bjorkqvist, AM
Karhu, R
Pelin, K
Linnainmaa, K
Tammilehto, L
Mattson, K
Kallioniemi, OP
Knuutila, S
机构
[1] HELSINKI UNIV,DEPT MED GENET,FIN-00014 HELSINKI,FINLAND
[2] FINNISH INST OCCUPAT HLTH,DEPT IND HYG & TOXICOL,HELSINKI,FINLAND
[3] DEPT EPIDEMIOL,HELSINKI,FINLAND
[4] TAMPERE UNIV,INST MED TECHNOL,CANC GENET LAB,SF-33101 TAMPERE,FINLAND
[5] TAMPERE UNIV HOSP,TAMPERE,FINLAND
[6] UNIV CENT HOSP,DEPT PULM MED,HELSINKI,FINLAND
关键词
CHROMOSOMAL-ABNORMALITIES; CYTOGENETIC ANALYSIS; SOLID TUMORS; CELL-LINES; DELETIONS; CANCER; P53;
D O I
10.1016/0165-4608(95)00358-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The molecular basis of malignant mesothelioma is poorly known. We examined genetic changes in 11 mesothelioma specimens by comparative genomic hybridization (CGH). Five DNA specimens originated from uncultured tumor tissues and six from cell lines established from the same patients. Findings from the classical karyotypic characterization of both primary tumors and cell lines have been reported previously. In the CGH analyses the most common generic alterations in the II mesothelioma specimens were losses of chromosomal regions in 1p, 8p, 14q, and 22q and gains of 5p, 6p, 8q, 15q, 17q, and 20. The cell lines had on average a much higher total number of genetic changes than the uncultured tumor specimens. Clonal relationship between the cell lines and the uncultured tissue specimens could not usually be demonstrated even though they originated from the same patient. The observed differences may partly be due to high frequency of chromosomal rearrangements, which CGH cannot detect, partly due to contamination of tumor specimens with normal tissue, and partly due to genetic evolution in tumor cell lines.
引用
收藏
页码:7 / 13
页数:7
相关论文
共 22 条
  • [1] BROWNE K, 1986, LANCET, V2, P167
  • [2] CHENG JQ, 1993, CANCER RES, V53, P4761
  • [3] COMPARATIVE GENOMIC HYBRIDIZATION, ALLELIC IMBALANCE, AND FLUORESCENCE IN-SITU HYBRIDIZATION ON CHROMOSOME-8 IN PROSTATE-CANCER
    CHER, ML
    MACGROGAN, D
    BOOKSTEIN, R
    BROWN, JA
    JENKINS, RB
    JENSEN, RH
    [J]. GENES CHROMOSOMES & CANCER, 1994, 11 (03) : 153 - 162
  • [4] COTE RJ, 1991, CANCER RES, V51, P5410
  • [5] DETECTION OF COMPLETE AND PARTIAL CHROMOSOME GAINS AND LOSSES BY COMPARATIVE GENOMIC INSITU HYBRIDIZATION
    DUMANOIR, S
    SPEICHER, MR
    JOOS, S
    SCHROCK, E
    POPP, S
    DOHNER, H
    KOVACS, G
    ROBERTNICOUD, M
    LICHTER, P
    CREMER, T
    [J]. HUMAN GENETICS, 1993, 90 (06) : 590 - 610
  • [6] FEARON ER, 1990, CELL, V61, P758
  • [7] CYTOGENETIC ANALYSIS OF MALIGNANT MESOTHELIOMA
    HAGEMEIJER, A
    VERSNEL, MA
    VANDRUNEN, E
    MORET, M
    BOUTS, MJ
    VANDERKWAST, TH
    HOOGSTEDEN, HC
    [J]. CANCER GENETICS AND CYTOGENETICS, 1990, 47 (01) : 1 - 28
  • [8] KARYOTYPIC CHANGES IN THE PRECLINICAL AND SUBSEQUENT STAGES OF MALIGNANT MESOTHELIOMA - A CASE-REPORT
    HANSTEEN, IL
    HILT, B
    LIEN, JT
    SKAUG, V
    HAUGEN, A
    [J]. CANCER GENETICS AND CYTOGENETICS, 1993, 70 (02) : 94 - 98
  • [9] DETECTION AND MAPPING OF AMPLIFIED DNA-SEQUENCES IN BREAST-CANCER BY COMPARATIVE GENOMIC HYBRIDIZATION
    KALLIONIEMI, A
    KALLIONIEMI, OP
    PIPER, J
    TANNER, M
    STOKKE, T
    CHEN, L
    SMITH, HS
    PINKEL, D
    GRAY, JW
    WALDMAN, FM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 2156 - 2160
  • [10] COMPARATIVE GENOMIC HYBRIDIZATION FOR MOLECULAR CYTOGENETIC ANALYSIS OF SOLID TUMORS
    KALLIONIEMI, A
    KALLIONIEMI, OP
    SUDAR, D
    RUTOVITZ, D
    GRAY, JW
    WALDMAN, F
    PINKEL, D
    [J]. SCIENCE, 1992, 258 (5083) : 818 - 821